1442 record(s) found for ""
- t-test
- 5-HT3 receptor antagonists
- Abbreviations
- Abiraterone acetate
- Ablation
- Abscess
- Absolute poverty
- Absorbable fibrin sealant patch
- Absorbable gelatin sponge
- Abstinence
- Acanthosis nigricans
- Acceptability
- Access to affordable essential drugs
- Access to health services
- Access to palliative care and pain relief
- Accessibility
- Accountability
- Accreditation
- Acetaminophen (paracetamol)
- Acetylcysteine
- Acid sensing ion channels
- Acquired immunodeficiency syndrome (AIDS)
- Active dying
- Active surveillance
- Activities of daily living (ADLs)
- Acupuncture
- Acute care
- Acute HIV infection
- Acute intoxication
- Acute leukemia
- Acute pain
- Acute radiation syndrome
- Acute urinary retention
- Acyclovir sodium
- Addiction
- Addison disease
- Adenocarcinoma
- Adenosine 5-triphosphate (ATP)
- Adherence
- Adhesions
- Adjustment disorders
- Adjuvant analgesics
- Adjuvant therapy
- Advance care directive / Advance care plan
- Advance directives: myths
- Advanced kidney disease
- Advanced kidney disease: end-of-life care
- Adverse drug reaction
- Advocacy
- Advocacy (for health)
- Affect
- Affordability
- Aganglionic megacolon
- Age-adjusted mortality rate
- Age-specific mortality rate
- Ageing
- Ageing and health: facts
- Agnosia
- Agonist
- Agoraphobia
- Aides in palliative care
- AIDS dementia complex
- AIDS-related cancer
- AIDS-related complex
- Akathisia
- Akathisia: Psychoactive medications
- Alendronate sodium
- Alfentanil hydrochloride
- Allied health personnel
- Allodynia
- Allow natural death order (AND)
- Aloe vera gel
- Alogia
- Alopecia
- Alpha-amino-3-hydroxy-5 methyl-4 isoxazole-propionic acid (AMPA)
- Alprazolam
- Altered mental status in the elderly
- Alternative medicine for cancer
- Alzheimer's disease
- Ambulatory care
- American ginseng
- Aminophylline
- Amnesia
- Amoxicillin-clavulanate potassium
- Ampicillin sodium / sulbactam sodium
- Amyotrophic lateral sclerosis (Lou Gehrig’s disease)
- Analgesia
- Analgesic drugs and metabolism
- Analgesic ladder
- Analgesic tolerance
- Analysis of variance (ANOVA)
- Anemia
- Anesthesia
- Anesthesia dolorosa
- Angiogenesis
- Angiography
- Anhedonia
- Anorexia
- Anorexia cachexia syndrome
- Antacids
- Antagonist
- Anti-androgens
- Anti-estrogens
- Antibiotic
- Antibody
- Anticholinergics (antimuscarinics)
- Anticipatory grief
- Anticonvulsants (antiepileptics)
- Antidepressant
- Antiemetics
- Antifibrinolytics
- Antifungals
- Antigen
- Antigen-antibody complex
- Antimicrobial therapy
- Antioxidants
- Antipsychotics
- Antiretroviral therapy
- Antitussives
- Anxiety
- Anxiety and depression: PHQ-4 screening tool
- Anxiety in palliative care
- Anxiety: GAD-7 scale
- Anxiety: guided imagery
- Anxiety: pharmacological management
- Anxiolytic
- Anxiousness
- Aphasia
- Arachidonic acid
- Aromatase inhibitors
- Aromatherapy
- Ascites
- Ascites in cancer patients
- Aspartate
- Aspirin (acetylsalicylic acid)
- Assessing the decision-making capacity
- Assessment / Multidimensional assessment
- Assisted dying
- Assisted suicide
- Asthenia
- Asymptomatic cancer
- Ataxia
- Attachment security, avoidance and anxiety
- Audit circle
- Auditory brainstem response (ABR) test
- Autonomic neuropathy
- Autonomy
- Availability
- Average length of care
- Avoidable and premature deaths and serious health-related suffering (SHS)
- Ayurveda
- Bach flower remedies
- Baclofen
- Bad news
- Bad news - fundamental communication skills
- Bad news – Robert Buckman's six-step protocol for breaking bad news
- Bad news – SPIKES protocol for breaking bad news
- Bambuterol hydrochloride
- Baseline
- Basic needs
- Basic palliative care training
- Beck Depression Inventory (BDI)
- Beclometasone
- Bed availability
- Bed day
- Bedside teaching
- Beers List
- Behavior therapy
- Benchmark
- Beneficence
- Beneficiaries
- Benefit
- Benzodiazepines
- Benzydamine hydrochloride
- Bereavement
- Best practice
- Betamethasone
- Bias
- Bioavailability
- Bioethics
- Biological therapy for cancer
- Biomedical model
- Biopsychosocial model
- Bisphosphonates
- Bladder lavage
- Bladder spasms
- Bleeding
- Bleeding in palliative care
- Bone marrow examination
- Bone marrow transplant and peripheral blood stem cell transplantation
- Bowel obstruction
- Bradykinin
- Brain death
- Brand name
- Breakthrough pain
- Brief Oral Health Status Examination (BOHSE)
- Bromazepam
- Brompton cocktail
- Bucket list
- Buclizine
- Budd-Chiari syndrome
- Budesonide / formoterol fumarate dihydrate inhalation aerosol
- Budget
- Buprenorphine
- Bupropion hydrochloride
- Burnout
- Buspirone hydrochloride
- Cachexia
- CAGE questionnaire
- Calcitonin gene-related peptide (CGRP)
- Cancer
- Cancer of unknown primary origin
- Cancer screening
- Cancer survivorship care plans (SCPs)
- Cancer-related fatigue
- Cancerophobia
- Candidiasis
- Cannabidiol (CBD) in palliative care
- Cannabidiol versus tetrahydrocannabinol for palliative care symptoms
- Cannabinoids
- Cannabis / Marijuana (ganja, hash, hashish)
- Cannabis for symptom control
- Cannabis: epidemiology
- Capacity
- Capacity assessment
- Capacity-building
- Capitation
- Capsaicin
- Carbamazepine
- Carbocisteine
- Carcinoid syndrome
- Carcinoma
- Cardiopulmonary Resuscitation (CPR)
- Care at the end of life: appropriate or inappropriate
- Caregiver
- Caregiver support
- Carotid blowout
- Case series
- Case-based payment
- Case-control study
- Case-fatality ratio or rate
- Case-mix
- Catatonia
- Catchment area
- Cauda equina syndrome
- Causalgia
- Cause-specific mortality rate
- CD4 cell count
- Celecoxib
- Celiac (coeliac) plexus block
- Central nervous system cancers
- Central pain
- Central sensitization (wind-up)
- Centralization
- Certification
- Cervical cancer
- Cetirizine
- Chemical coping
- Chemoembolization
- Chemoimmunotherapy
- Chemoprevention
- Chemoprotective agent
- Chemoradiation
- Chemotherapy near the end of life
- Chemotherapy-induced acral erythema
- Chemotherapy: response and survival data
- Cheyne-Stokes respiration
- Chiropractic
- Chlorhexidine/ethyl alcohol mouthwash
- Chlorpheniramine maleate
- Chlorpromazine
- Chronic and complex condition
- Chronic care
- Chronic critical illness in adults
- Chronic dyspnea
- Chronic heart failure
- Chronic liver failure
- Chronic obstructive pulmonary disease (COPD)
- Chronic obstructive pulmonary disease (COPD): evolving therapies which can palliate symptoms
- Chronic obstructive pulmonary disease (COPD): patients who need palliative care
- Chronic obstructive pulmonary disease (COPD): prognosis
- Chronic pain syndrome
- Circadian rhythms
- Citalopram hydrobromide
- Clerkships
- Clinical audit
- Clinical Frailty Scale (CFS)
- Clinical guideline
- Clinical research and clinical trials
- Clinical study report
- Clinical trial
- Clinicians: managing one’s emotions
- Clodronate disodium
- Clotrimazole
- Co-creation
- Co-insurance (rate)
- Cochrane
- Codeine phosphate
- Coffee enemas
- Cognitive-behavioral therapies
- Cohort study
- Cold therapy
- Collusion
- Colon cancer staging
- Coma
- Comfort care
- Common regrets at the end of life
- Communication
- Communication skills
- Community
- Community effectiveness
- Community health
- Compassion
- Compassion fatigue
- Compassionate community
- Compassionate use
- Competence
- Complementary and alternative medicine (CAM)
- Complex chronic disease
- Complex regional pain syndrome
- Compliance
- Complicated grief
- Complicated grief disorder
- Compulsory health insurance
- Computed tomography (CT/CAT) scanning
- Confidence interval
- Confirmed carcinoma of unknown primary
- Conflict of interest
- Confusion Assessment Method (CAM)
- Consensus building
- Consequentialism
- Constipation
- Consultation
- Consultation in the emergency department
- Continuing education
- Continuity of care
- Contract
- Contract model
- Control group
- Copayment
- Coping
- Cordotomy / Percutaneous cervical cordotomy
- Corticosteroids
- Corticosteroids & psychiatric symptoms
- Corticosteroids: bone pain
- Corticosteroids: palliative care symptoms
- Cost analysis
- Cost containment
- Cost minimization
- Cost of illness (study)
- Cost-benefit analysis
- Cost-effectiveness analysis
- Cost-sharing
- Cost(s)
- Cough
- Counseling
- Coverage
- COVID-19
- COVID-19 context: coronaphobia
- COVID-19 context: palliative home care of non-ventilated patients
- COVID-19 context: when to refer cancer patients for specialist palliative care
- COVID-19 context: when to refer patients with neurological disorders for specialist palliative care
- COVID-19 context: when to refer patients with serious illness for specialist palliative care
- COVID-19: a triage algorithm for low-income settings
- COVID-19: palliative care
- COVID-19: referral criteria for specialist palliative care
- COVID-19: triage tool for referral to palliative care
- Creutzfeldt-Jakob disease (prion disease)
- Crisis
- Criteria
- Cross-sectional study
- Cross-tolerance
- Crude death rate
- Crude mortality rate
- Crusades
- Cumulative grief
- Curriculum
- Cyclizine
- Cyclo-oxygenase (COX)
- Cyproheptadine hydrochloride
- Cystic fibrosis
- Dame Cicely Saunders
- Darifenacin
- Daughters of Charity
- Day care
- Day case
- Day hospice
- Deafferentation pain
- Death
- Death and the afterlife
- Death rattle
- Deathbed visions
- Decision-making capacity
- Deductible
- Deep vein thrombosis
- Defense mechanism
- Defined daily dose (DDD)
- Dehydration (Hypovolemia)
- Delirium
- Delirium tremens
- Delirium vs. dementia
- Delirium: management
- Demand
- Dementia I
- Dementia with Lewy bodies
- Dementia: Abbey Pain Scale
- Dementia: AD8 screening interview
- Dementia: assessment of discomfort
- Dementia: deprescribing cholinesterase inhibitors
- Dementia: DSQIID screening quetionnaire
- Dementia: end of life
- Dementia: medications in palliative care
- Dementia: pain assessment
- Demoralization and death anxiety
- Demoralization syndrome
- Denial
- Deontological ethics
- Dependence syndrome
- Deprescribing
- Deprescribing benzodiazepines
- Deprescribing: Communication techniques
- Depressant
- Depression (major depressive disorder)
- Depression in palliative care
- Depression: Endicott substitution criteria
- Depression: non-oral pharmacotherapy
- Depression: oral pharmacotherapy
- Depression: PHQ-9 scale
- Depressivity
- Dermatome
- Dermatomyositis
- Development
- Dexamethasone
- Dexamphetamine
- Dextroamphetamine-amphetamine
- Dextropropoxyphene hydrochloride
- Diabetes insipidus
- Diabetes management in palliative care
- Diagnosis
- Diagnosis-related groups
- Diagnostic and Statistical Manual of Mental Disorders (DSM)
- Diamorphine (heroin)
- Diarrhea (diarrhoea)
- Diclofenac
- Dietary and nutritional therapies
- Dignified death
- Dignity
- Diphenhydramine hydrochloride
- Direct patient expenditure
- Disability
- Disability-Adjusted Life Year (DALY)
- Disadvantaged / vulnerable / marginalized groups
- Discharge
- Discrimination
- Disease
- Disease-free survival rate
- Disenfranchised grief
- Disorder
- Disorders of consciousness
- Dispensary
- Distress
- Distress in the terminally ill
- Distress thermometer
- Do not resuscitate (DNR)
- Do not resuscitate: recommendation for patients with advanced illness
- Domain
- Dosage
- Dosage form
- Dose
- Double effect
- Double-blind study
- Droperidol
- Drug
- Drug antagonism
- Drug interaction
- Drug interaction checker
- Drug policy
- Drug-seeking behavior
- Duloxetine hydrochloride
- Durable power of attorney for health care
- Dying
- Dying at home: the burden of medication management
- Dying patient
- Dying patient: physical examination
- Dysarthria
- Dysesthesia (dysaesthesia)
- Dyskinesia
- Dysphagia
- Dyspnea (dyspnoea)
- Dyspnea: assessment tools at the end of life
- Dyspnea: behavioral assessment
- Dyssomnias
- Dysthymia
- Dystonia
- Early detection
- ECOG score
- Economic analysis / evaluation
- Economic benefits of palliative care provision
- Economic model
- Edmonton Classification System for Cancer Pain (ECS-CP)
- Edmonton Functional Assessment Tool (EFAT)
- Edmonton Labeled Visual Information System (ELVIS)
- Edmonton Staging System (ESS)
- Edmonton Symptom Assessment System (ESAS)
- Education in Palliative and End-of-Life Care (EPEC)
- Effectiveness
- Efficacy
- Efficiency
- eHealth (e-health)
- Elder-life calculator for frail older adults
- Elisabeth Kübler-Ross
- Emergency admission
- Emotion
- Emotional lability
- Emotions of health care professionals
- Empathy
- Empowerment - Enabling
- Encephalopathy
- End of life
- End-of-life care
- End-of-life decisions: Locked-in Syndrome (LIS)
- End-of-life goals
- End-of-Life Nursing Education Consortium (ELNEC)
- End-stage liver disease
- Endometrial cancer
- Energy therapies
- EPEC – India
- Epidemic
- Epidemiological research
- Epidemiology
- Epidermal growth factor (EGF)
- Epilepsy
- Epinephrine
- Episodic pain
- Epoetin alfa / beta / zeta
- Equianalgesic dose / equianalgesic chart
- Equity / Equity in health
- Escitalopram
- Esomeprazole magnesium
- Essential medicines
- Essential medicines in palliative care
- Essential Opioid Prescription Package (OEPP)
- Essential practices in palliative care
- Estimated opioid need
- Ethical dilemma
- Ethical principles
- Ethicist
- Ethics
- Ethics committee
- Ethnicity
- Etiology (Aetiology)
- Euthanasia
- Evaluation
- Evidence base
- Evidence-based health care
- Evidence-based medicine
- Existential pain
- Family
- Family medicine
- Family meeting
- Family-focused grief therapy (FFGT)
- Fatigue
- Febrile neutropenia
- Fecal impaction (faecal impaction)
- Fecal incontinence (faecal incontinence)
- Fecal incontinence in palliative care settings
- Fee-for-service
- Fentanyl citrate
- Ferrous fumarate / sulfate
- Fibromyalgia
- Fibrositis
- Five-year relative survival rate
- Five-year survival rate
- Flatulence
- Fluconazole
- Flurbiprofen
- Fluticasone
- Formulation
- Frailty
- Frequencies
- Frequent physical complaints
- Full-time / Part-time
- Functional Assessment Staging (FAST)
- Fungating tumors
- Furosemide
- Futility
- Gabapentin
- Ganciclovir
- Gastrostomy
- Gender
- General (medical) practitioner (GP)
- General palliative care
- Generic medicines
- Genogram
- Glioblastoma
- Global health
- Glutamate
- Glycopyrrolate
- Goal
- Goals of care: what does it mean?
- Gold standard
- Good clinical practice
- Good death
- Goodbye over the phone
- Granisetron hydrochloride
- Grief
- Gross domestic product (GDP)
- Gross national product
- Growth factors and tumor treatment
- Guideline
- Guidelines for determining prognosis
- Guidelines for determining prognosis: amyotrophic lateral sclerosis (ALS)
- Guidelines for determining prognosis: dementia
- Guidelines for determining prognosis: heart disease
- Guidelines for determining prognosis: HIV disease
- Guidelines for determining prognosis: liver disease
- Guidelines for determining prognosis: renal disease
- Guidelines for determining prognosis: stroke and coma
- Gynecomastia (Gynaecomastia)
- H2 receptor antagonists
- Halitosis
- Hallucination
- Haloperidol
- Hazardous drugs
- Healing (faith/spiritual)
- Health
- Health care
- Health care delivery models
- Health care levels
- Health care policy
- Health care resources
- Health care system
- Health center
- Health determinants
- Health development
- Health economics
- Health education
- Health equity
- Health expectancy
- Health gain
- Health indicator
- Health inequality and inequity
- Health insurance
- Health literacy in palliative care
- Health outcome
- Health plan
- Health policy
- Health proficiency
- Health promotion
- Health resources
- Health service
- Health status
- Health system
- Health workforce
- Health-related suffering / Serious health-related suffering (SHS)
- Heart failure
- Heart failure: end-of-life care
- Heart failure: palliative care
- Heart failure: refractory end-stage
- Heat therapy
- Helicobacter pylori infection
- Hemostatics (Haemostatics)
- Hepatic encephalopathy
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Hepatorenal syndrome (HRS)
- Hepatotoxicity
- Herbal medicine
- Herceptin (trastuzumab)
- Herpes simplex virus 1 (HSV-1) infection
- Herpes simplex virus 2 (HSV-2) infection
- Herpes zoster
- Hiccups
- Histamine
- HIV / AIDS
- HIV post-exposure prophylaxis
- HIV-associated neurocognitive disorders
- HIV-infected patients with central nervous system lesions
- Hodgkin’s lymphoma
- Holistic
- Home care
- Home palliative care team
- Home-based palliative care
- Homeopathy
- Honesty
- Hope
- Hospice
- Hospital
- Hospital bed
- Hospital palliative care support team
- Hospitallers
- Hostility
- Housekeeper / Maid services (USA) / Home help (UK)
- Human capital
- Human Development Index
- Humor
- Huntington’s disease
- Hydration
- Hydrocortisone sodium succinate
- Hydromorphone hydrochloride
- Hydrotherapy
- Hyoscine
- Hyperalgesia
- Hypercalcemia of malignancy
- Hyperesthesia (Hyperaesthesia)
- Hyperhidrosis
- Hyperpathia
- Hypersomnia
- Hypervigilance
- Hypnotherapy
- Hypoalgesia
- Hypodermoclysis
- Hypoesthesia
- Hyponatremia
- Hyponatremia treatment
- IAHPC position on euthanasia and physician-assisted suicide
- Ibandronate sodium
- Ibuprofen
- Ichthyosis
- Idiopathic pulmonary fibrosis
- Illicit drug
- Illness
- Illness trajectories
- Illusion
- Immunotherapy in cancer
- Immunotherapy in cancer: Adverse effects
- Implementation
- Incidence
- Incident pain
- Indicator
- Indinavir sulfate
- Indomethacin
- Infections and antibiotics at the end of life
- Infectious / Communicable diseases
- Informal caregivers
- Informed consent
- Inpatient
- Inpatient hospice
- Insomnia
- Insomnia: non-pharmacologic treatments.
- Insomnia: pharmacologic treatments
- Institutions
- Integrated care pathway
- Integrated model
- Interdisciplinary / Multidisciplinary care team
- Internal medicine
- International Association for Hospice and Palliative Care (IAHPC)
- International Association for the Study of Pain (IASP)
- International Classification of Diseases (ICD)
- International HIV Dementia Scale (IHDS)
- International Narcotics Control Board (INCB)
- International Network for Cancer Treatment and Research (INCTR)
- International Nonproprietary Name (INN)
- Internationally controlled essential medicines
- Internationally controlled substances
- Interquartile range
- Intervention
- Interventional radiology
- Intimate partner violence
- Intra-osseous injections
- Intractable symptom
- Ipratropium bromide
- Irish Sisters of Charity
- Iron sucrose injection
- Ischemic limb pain
- Jugular foramen syndrome
- Justice
- Kaposi´s sarcoma
- Karnofsky score (KPS)
- Kennedy terminal ulcer
- Ketamine hydrochloride
- Ketamine: its role in depression
- Ketoconazole
- Ketorolac
- Knowledge management
- Lactulose
- Laetrile
- Lamotrigine
- Lancet Essential Package for Pain Relief and Palliative Care
- Last days of life
- Laxatives and antidiarrheals
- Legal framework
- Length of care
- Length of stay
- Leptomeningeal carcinomatosis
- Leser-Trélat sign
- Lethargy
- Leukemia
- Levocetirizine
- Levodopa
- Lhermitte's phenomenon
- Licensing
- Life closure
- Life expectancy
- Life expectancy at birth
- Life review
- Life support measures
- Life-limiting condition
- Life-threatening condition
- Likert scale
- Liquid biopsy
- Lived experience
- Living will
- Lobbying
- Long-term care
- Long-term condition
- Long-term oxygen therapy
- Longitudinal study
- Loperamide hydrochloride
- Lorazepam
- Lymphangitic carcinomatosis
- Lymphedema (lymphoedema)
- Lymphedema in palliative care
- Lymphoma
- Macrogol / polyethylene glycol oral osmotic laxative
- Magnesium citrate
- Magnesium hydroxide
- Magnetic resonance imaging (MRI)
- Malignancy of undefined primary origin
- Malignant psoas syndrome
- Malignant spinal cord compression (MSCC)
- Malignant superior vena cava syndrome
- Malignant wounds
- Managed care
- Management
- Massage therapy
- Mastectomy
- Mean. Median. Mode.
- Meaning
- Median overall survival
- Medical Assistance in Dying (MAiD)
- Medical condition
- Medical error
- Medical Subject Headings (MeSH)
- Medication disposal
- Medicine
- MEDLINE
- Medroxyprogesterone
- Megestrol acetate
- Meloxicam
- Member State
- Memorial Delirium Assessment Scale (MDAS)
- Meningitis
- Mental health condition
- Meperidine hydrochloride (pethidine)
- Meta-analysis
- Metabolism
- Metastasis
- Methadone hydrochloride
- Methadone: non-oral routes
- Method
- Methylphenidate hydrochloride
- Methylprednisolone
- Metoclopramide hydrochloride
- Metronidazole hydrochloride
- Midazolam hydrochloride
- Mild cognitive impairment
- Millennium development goals / 2030 agenda for sustainable development.
- Mind-body approaches
- Mindfulness
- Mindfulness: self-care strategies for clinicians
- Mini Mental State Examination (MMSE)
- Minimum data sets
- Mirtazapine
- Modafinil
- Models of palliative interventions in chronic advanced palliative care
- Monitoring
- Mood
- Morbidity
- Morbidity rate
- Morphine equivalent daily dose (MEDD)
- Morphine sulfate
- Mortality rate
- Mourning
- Multicenter study
- Multiple sclerosis
- Multivitamin
- Muscular dystrophy
- Music therapy
- Music-thanatology
- Myasthenic syndrome (Lambert-Eaton syndrome)
- Myoclonus
- N-Methyl D Aspartate (NMDA)
- N-of-1 trials
- Nabilone
- Naloxone hydrochloride
- Naltrexone hydrochloride
- Nandrolone decanoate
- Naproxen
- Narcotic bowel syndrome (NBS)
- Narcotic drug
- Naturopathy
- Nausea
- Nausea and vomiting
- Near death awareness
- Need
- Needs-based end-of-life care
- Neoadjuvant therapy
- Neoplastic fever
- Nerve block / Neurolysis
- Nerve growth factor (NGF)
- Network
- Neuralgia
- Neuroexcitatory effects of opioids
- Neurogenic pain
- Neuroleptic
- Neuroleptic (antipsychotic) malignant syndrome (NMS)
- Neurological complications of HIV infection
- Neurological condition
- Neuropathic pain
- Neuropathic pain: Antiepileptic drugs
- Neuropathic pain: Opioids analgesics
- Neuropathy
- Niemann-Pick disease
- Nightmares
- Nociceptive pain
- Non-malignant causes of low back pain in palliative care patients
- Non-treatment decisions
- Noncommunicable diseases (NCDs)
- Noncommunicable diseases: risk factors
- Nongovernmental organizations (NGOs)
- Nonmaleficence
- Nonmedical use
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Nonverbal communication
- Norethindrone acetate
- Norm
- Number needed to treat (NNT)
- Number of days/years gained or lost
- Numeric rating scale (NRS)
- Objective
- Observational study
- Obstipation (obstinate constipation)
- Occult primary tumor
- Occupancy rate
- Occupational therapist
- Octreotide acetate
- Odds / Odds Ratio (OR)
- Olanzapine
- Older adults: Opioid analgesia
- Older adults: Pain management
- Omeprazole
- Oncology
- Ondansetron hydrochloride
- Open access publication
- Opiate / Opioid / Endogenous opioid / Opioid analgesic
- Opioid – physical dependence
- Opioid – psychological dependence
- Opioid – tolerance
- Opioid abuse
- Opioid allergic reactions
- Opioid availability
- Opioid escalation index (OEI)
- Opioid overdose: how to respond
- Opioid regulation
- Opioid regulation: consequences
- Opioid rotation (substitution)
- Opioid safety recommendations in adult palliative medicine
- Opioid-induced bowel dysfunction (OIBD)
- Opioid-induced constipation
- Opioid-induced hyperalgesia
- Opioids and pregnancy
- Opioids and renal failure
- Opioids and safe driving
- Opioids diversion risk.
- Opioids for noncancer pain
- Opioids: screening risk factors of substance abuse
- Opiophobia
- Opium tincture
- Opportunistic infection
- Optic neuritis
- Oral care: focused history and examination in palliative care patients
- Oral health issues in palliative care
- Oral mucositis
- Originator pharmaceutical product / originator brand
- Oropharyngeal candidiasis
- OSCE (Objective structured clinical examination)
- Ostomy
- Out-of-pocket payments
- Outcome
- Outpatient
- Output
- Ovarian cancer
- Overdose
- Overflow diarrhea (spurious diarrhea)
- Overflow diarrhea: management
- Overmedicalized death
- Oxycodone / naloxone combination
- Oxycodone hydrochloride
- P value
- Pacemakers
- Pain
- Pain assessment in nonverbal elders
- Pain assessment in the cognitively impaired
- Pain assessments in older patients with limited ability to communicate
- Pain management in cancer patients
- Pain management in cancer patients: parenteral lidocaine
- Pain management in critically ill end-of-life patients
- Pain or substance use disorder?
- Pain thermometer
- Pain threshold
- Pain tolerance level
- Pain: pediatric assessment scales
- Pain: terminology
- Palliation
- Palliative care - 1990, 2002 and 2023 WHO definitions
- Palliative care - 2018 IAHPC consensus based definition
- Palliative care & cancer survivors
- Palliative care approach
- Palliative care consultation
- Palliative care early involvement: caregiver quality of life
- Palliative care in acute myocardial infarction
- Palliative care in the emergency department
- Palliative care network
- Palliative Care referral criteria
- Palliative care syringe
- Palliative care system
- Palliative care team
- Palliative care unit
- Palliative care vs. hospice care
- Palliative care: acceptance of the term
- Palliative care: early integration
- Palliative medicine
- Palliative outpatient clinic
- Palliative performance scale (PPS)
- Palliative Prognostic Score (PaP)
- Palliative rehabilitation
- Palliative sedation
- Palliative-care patients and safe driving
- Pamidronate disodium
- Pancoast syndrome
- Panic attack
- Paracentesis
- Paramedical staff
- Paraneoplastic neurological syndromes
- Paraneoplastic syndromes
- Parasomnias
- Parenteral fluids at the end of life
- Parenteral nutrition and hydration: beliefs and perception
- Paresthesia (paraesthaesia)
- Parkinson's disease
- Parkinson's disease: integrated outpatient palliative care
- Parkinson’s disease: disease trajectory.
- Parkinson’s disease: palliation for non-motor symptoms
- Paroxetine hydrochloride
- Participatory approach
- Pastoral counselor
- Paternalism
- Patient
- Patient diagnosis
- Patient- and family-centered care
- Patient-centred care
- Patient-controlled analgesia (PCA)
- Patients' priorities for medical care
- Patients´ rights
- Payment
- Pearson correlation
- Pediatric palliative care
- Peer review
- Per-diem charge / fee / payment
- Percentile
- Percocet
- Pericardial effusion
- Perinatal transmission
- Peripheral nervous system
- Peripheral neuropathic pain
- Peripheral neuropathy
- Persistent pain in cancer survivors
- Personality
- Petrolatum-mineral oil-lanolin-ceresin ointment
- Pharmaceutical product
- Pharmacist
- Pharmaco-therapeutic referrals (classification of)
- Pharmacodynamics
- Pharmacokinetics
- Phenobarbital
- Phlebitis
- Phlegm
- Phobia
- Physical dependence
- Physical examination
- Physical medicine and rehabilitation
- Physician-assisted death (PAD)
- Physician-assisted suicide
- Physicians orders for life sustaining treatment (POLST)
- Physiotherapy
- Piroxicam
- Place of residence
- Placebo
- Plan of care
- Planning
- Pleural effusion
- Pneumonia
- Policy
- Polycythemia vera
- Polymodal C-fiber receptors
- Polypharmacy
- Population and needs-based planning for care at the end of life
- Positive airway pressure
- Post-herpetic neuralgia (PHN)
- Posttraumatic stress disorder (PTSD) in palliative care
- Potential years of life lost
- Povidone-iodine solution
- Power
- Power of attorney
- Prednisolone
- Prednisone
- Preexisting condition
- Pregabalin
- Pressure ulcers
- Prevalence
- Preventive medicine
- Primary and specialist-level palliative care services.
- Primary endpoint (of a clinical trial)
- Primary health care (PHC)
- Primary lateral sclerosis
- Primary palliative care
- Primary palliative care provider
- Primary specialist providers
- Private health care expenditure
- Private patient
- Process
- Prochlorperazine
- Prodrome
- Productivity
- Professional competence
- Professional-patient boundaries in palliative care
- Profit
- Progestogens
- Prognosis
- Prognosis in HIV and AIDS
- Prognostication
- Program
- Progressive multifocal leukoencephalopathy (PML)
- Progressive neurologic disorders
- Progressive supranuclear palsy
- Project
- Promethazine hydrochloride
- Prophylactic
- Prophylactic cranial irradiation
- Propofol
- Proportionate mortality
- Protocol
- Proton pump inhibitors (PPIs)
- Provider
- Provisional carcinoma of unknown primary
- Proxy
- Pruritus
- Pseudo-addiction
- Psychiatry
- Psychoactive substance
- Psychoactive substance use disorder
- Psychoanalytically oriented psychoterapies
- Psychogenic pain
- Psychological approaches to pain management
- Psychological dependence
- Psychological distress
- Psychology
- Psychometric measures
- Psychomotor agitation
- Psychomotor retardation
- Psychosocial assessment in palliative care
- Psychosocial interventions
- Psychostimulants
- Psychoticism
- Psychotomimetic
- Public health
- Public health care expenditure
- Public health care sector
- PubMed Central
- Pulmonary disease: guidelines for determining prognosis
- Pulmonary embolism
- Pulmonary infections
- Pulmonary rehabilitation
- Pulse oximetry
- Purchaser
- Qualitative research
- Quality
- Quality assurance
- Quality control
- Quality of life
- Quality of life in palliative care
- Quality of medical care
- Quality-Adjusted Life Year (QALY)
- Quantitative research
- Quetiapine
- Radiation brachytherapy
- Radiation enteritis
- Radiation necrosis
- Radiation sickness syndrome
- Radiation therapy
- Radioactive drug
- Radioactive iodine
- Radioactive palladium
- Radioactive seed
- Radioembolization
- Radiofrequency ablation
- Radionics
- Radiopharmaceuticals (radionuclides)
- Randomized controlled trial
- Recurrence
- Referral (medicine)
- Refractory ascites
- Refractory gastroesophageal reflux disease
- Refractory symptom
- Regulation
- Reiki
- Relative potency
- Remission
- Request for nondisclosure of medical information
- Rescue dose
- Research types
- Resilience
- Resource allocation
- Resources
- Respiratory depression
- Respiratory tract secretions
- Respite care
- Responding to patient emotions
- Restless legs syndrome
- Riluzole
- Risk
- Rituximab
- Rofecoxib
- Sadness
- Safe withdrawal of preventive drugs
- Salbutamol
- Salmeterol
- Sarcoma
- Sarcopenia
- Saying goodbye by phone
- Screening
- Screening tool for anxiety and depression
- Secondary health care
- Sedating agitated patients
- Senna extract
- Sensory changes
- Serious adverse drug reaction
- Serious health-related suffering (SHS)
- Serious illness
- Serious illness communication
- Serotonin (5-Hydroxy Tryptamine) (5HT)
- Serotonin syndrome (serotonin toxicity)
- Sertraline hydrochloride
- Setting of care
- Severe illness
- Severity of illness
- Sexuality
- Shark cartilage
- Shortness of breath
- Side effect
- Sign
- Simple linear regression
- Sleep-related disorders
- Social care
- Social health insurance
- Social security
- Social stigma
- Social work
- Social worker in palliative care
- Sodium biphosphate / sodium phosphate oral laxative
- Sodium carboxymethylcellulose dressing
- Sodium hyaluronate topical hydrogel
- Sodium picosulfate
- Sodium salicylate
- Somatic symptom and related disorders (previously somatoform disorders)
- Somatization disorder
- Somnolence (drowsiness)
- Specialist
- Specialist palliative care services
- Specialty
- Spinal stenosis
- Spiritual assessment: FICA spiritual history tool
- Spiritual assessment: HOPE questions
- Spiritual assessment: Spiritual-AIM
- Spiritual screening tool
- Spirituality
- Spirituality in palliative care
- Spironolactone
- Squashed stomach syndrome
- St John’s wort
- St. Christopher’s Hospice
- St. Joseph's Hospice
- Staging
- Stakeholders
- Standard
- Standard deviation
- Standardized mortality ratio / rate
- Statistical power
- Status epilepticus
- Steering group
- Stevens-Johnson syndrome
- Stimulant
- Strategy
- Stress
- Stroke / Cerebrovascular accident
- Stupor
- Subcutaneous furosemide
- Subsidy
- Substance use disorder
- Substance use disorders in palliative care
- Sudeck’s atrophy
- Suffering
- Suffering: intolerable, refractory
- Suicide
- Suicide among cancer survivors
- Suicide in patients with terminal conditions
- Sumatriptan
- Superior vena caval (SVC) obstruction
- Supply
- Supportive care
- Surgical oncology
- Surprise question
- Surprise question: a prognostic tool
- Surrogate decision-making
- Survey
- Survival rate
- Survivor
- Sustainability
- Symptom
- Symptom meaning
- Syndrome
- Syndrome of imminent death
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- Systematic review
- t-test
- Tamsulosine hydrochloride
- Tapentadol
- Tardive dyskinesia
- Targeted therapy
- Tay-Sachs disease
- Teamwork
- Telehealth
- Telehealth: a guide for a patient-assisted virtual physical examination
- Telehealth: basics
- Telehealth: palliative care
- Telemedicine: best practices in palliative care
- Tenesmus
- Terbutaline sulphate
- Terminal condition
- Terminal hemorrhage: management
- Tertiary health care
- The bare facts of substance abuse
- The Commission on Narcotic Drugs
- The Lancet Commission report on palliative care and pain relief
- The palliative care culture
- Theophylline
- Therapeutic community
- Therapeutic obstinacy
- Therapeutic relationship
- Therapeutic silence
- Therapeutic touch
- Third-party payer
- Thirst
- Thoracocentesis (Thoracentesis, or pleural tap)
- Tolerance
- Tolerance: opioid escalation index (OEI)
- Tolterodine
- Toolkit
- Topical counter-irritants
- Topical opioids for pain
- Topical treatments for acute and chronic wound pain
- Total expenditure on health
- Total pain
- Tracheostomy care
- Tracheotomy (or tracheostomy)
- Traditional medicine
- Tramadol
- Transcutaneous electric nerve stimulation (TENS)
- Transference and countertransference
- Transfusion dependence
- Transfusions and quality of life of cancer patients
- Transitions in palliative care in the 21st century: Concepts
- Transitions in palliative care in the 21st century: Model of care and organization
- Transitions in palliative care in the 21st century: Perspective for planning
- Transplant medication in palliative care
- Treatment
- Triage
- Triamcinolone
- Trifluoperazine hydrochloride
- Trousseau’s syndrome
- Trustworthiness in qualitative research
- Truth-telling
- Tumor debulking
- Tumor lysis syndrome (TLS)
- Uncertainty
- Undertreatment of cancer pain
- Unit of care
- Universal health coverage and health financing
- Universal health insurance
- Urban population / Rural population
- Urinary incontinence (UI)
- Utilization
- Valid consent
- Validity
- Valproic acid
- Values
- Vascular endothelial growth factor (VEGF)
- Verbal descriptor scale (VDS)
- Video conferencing platforms
- Visual Analogue Scale (VAS)
- Vitamin A
- Vitamin B12
- Vitamin D
- Vitamin E
- Voluntary stopping eating and drinking (VSED)
- Volunteer
- Volunteer hospice team
- Volunteer services manager
- Vomiting
- Vulnerability
- Vulnerable groups
- Vulvar and vaginal cancer
- Wasting syndrome
- Welfare
- Well-being
- What to tell the children when someone is dying
- Whipple’s procedure
- WHO (World Health Organization)
- WHO analgesic method
- WHO disease staging system for HIV infection and disease in adults and adolescents
- WHO disease staging system for HIV infection and disease in children
- WHO Model List of Essential Medicines
- WHO: managing cancer pain
- Whole person / Holistic care
- Withdrawal of dialysis
- Withdrawal of mechanical ventilation
- Withdrawal syndrome
- Working group
- Workshop
- World Hospice and Palliative Care Day
- Worry
- Wound odor
- Xerosis
- Xerostomia (dry mouth)
- Yoga
- Zoledronic acid
- Zollinger-Ellison syndrome (ZES)
- Zolmitriptan
- Zolpidem tartrate
- Zopiclone